Literature DB >> 17981624

Mechanism of nuclear calcium signaling by inositol 1,4,5-trisphosphate produced in the nucleus, nuclear located protein kinase C and cyclic AMP-dependent protein kinase.

Christian Klein1, Anant N Malviya.   

Abstract

Nuclear phospholipase C-gamma 1 can be phosphorylated by nuclear membrane located epidermal growth factor receptor sequel to epidermal growth factor-mediated signaling to the nucleus. The function of mouse liver phospholipase C-gamma 1 is attributed to a 120 kDa protein fragment which has been found to be a proteolytic product of the 150 kDa native nuclear enzyme. The tyrosine-phosphorylated 120 kDa protein band interacts with activated EGFR, binds phosphatidyl-3-OH kinase enhancer, and activates nuclear phosphatidylinositol-3-OH-kinase, and is capable of generating diacylglycerol in response to the epidermal growth factor signal to the nucleus in vivo. Thus a mechanism for nuclear production of inositol-1,4,5-trisphophate is unraveled. Nuclear generated inositol-1,4,5-trisphophate interacts with the inner membrane located inositol-1,4,5-trisphophate receptor and sequesters calcium into the nucleoplasm. Nuclear inositol-1,4,5-trisphophate receptor is phosphorylated by native nuclear protein kinase C which enhances the receptor-ligand interaction. Nuclear calcium-ATPase and inositol-1,3,4,5-tetrakisphophate receptor are located on the outer nuclear membrane, thus facilitating calcium transport into the nuclear envelope lumen either by ATP or inositol-1,3,4,5-tetrakisphophate depending upon the external free calcium concentrations. Nuclear calcium ATPase is phosphorylated by cyclic AMP-dependent protein kinase with enhanced calcium pumping activity. A holistic picture emerges here where tyrosine phosphorylation compliments serine phosphorylation of key moieties regulating nuclear calcium signaling. Evidence are forwarded in favor of proteolysis having a profound implications in nuclear calcium homeostasis in particular and signal transduction in general.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981624     DOI: 10.2741/2756

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  7 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  Lipid metabolism emerges as a promising target for malignant glioma therapy.

Authors:  Deliang Guo; Erica Hlavin Bell; Arnab Chakravarti
Journal:  CNS Oncol       Date:  2013-05

Review 4.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

5.  Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts.

Authors:  Yuh-Jiin I Jong; Vikas Kumar; Karen L O'Malley
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 6.  Lipid integration in neurodegeneration: an overview of Alzheimer's disease.

Authors:  Rajesh Singh Yadav; Neeraj Kumar Tiwari
Journal:  Mol Neurobiol       Date:  2014-03-05       Impact factor: 5.590

Review 7.  Intracellular calcium channels: inositol-1,4,5-trisphosphate receptors.

Authors:  Olena A Fedorenko; Elena Popugaeva; Masahiro Enomoto; Peter B Stathopulos; Mitsuhiko Ikura; Ilya Bezprozvanny
Journal:  Eur J Pharmacol       Date:  2013-12-01       Impact factor: 4.432

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.